| scholarly article | Q13442814 |
| P2093 | author name string | Shaw E | |
| Anagli J | |||
| Hagmann J | |||
| P2860 | cites work | L-trans-Epoxysuccinyl-leucylamido(4-guanidino)butane (E-64) and its analogues as inhibitors of cysteine proteinases including cathepsins B, H and L | Q24531160 |
| Gene organization of the small subunit of human calcium-activated neutral protease | Q24609799 | ||
| Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 | Q25938983 | ||
| A new generation of Ca2+ indicators with greatly improved fluorescence properties | Q27860793 | ||
| Active center differences between cathepsins L and B: the S1 binding region | Q28296432 | ||
| The identification of active forms of cysteine proteinases in Kirsten-virus-transformed mouse fibroblasts by use of a specific radiolabelled inhibitor | Q28342303 | ||
| The design of peptidyldiazomethane inhibitors to distinguish between the cysteine proteinases calpain II, cathepsin L and cathepsin B | Q28359859 | ||
| The synthesis of lysylfluoromethanes and their properties as inhibitors of trypsin, plasmin and cathepsin B | Q28360206 | ||
| Synthesis and properties of peptidyl derivatives of arginylfluoromethanes | Q28361238 | ||
| Inhibition of bone resorption in culture by inhibitors of thiol proteinases | Q28366137 | ||
| The inhibition of macrophage protein turnover by a selective inhibitor of thiol proteinases | Q28367093 | ||
| Molecular cloning of the cDNA for the large subunit of the high-Ca2+-requiring form of human Ca2+-activated neutral protease | Q34557016 | ||
| Cysteinyl proteinases and their selective inactivation | Q34656277 | ||
| Isolation and sequence analyses of cDNA clones for the large subunits of two isozymes of rabbit calcium-dependent protease | Q35046307 | ||
| Heterogeneity in late-onset metachromatic leukodystrophy. Effect of inhibitors of cysteine proteinases. | Q35198709 | ||
| Synergism of platelet-aggregating agents. Role of elevation of cytoplasmic calcium | Q35576249 | ||
| New calcium indicators and buffers with high selectivity against magnesium and protons: design, synthesis, and properties of prototype structures | Q36628858 | ||
| Brain spectrin, calpain and long-term changes in synaptic efficacy | Q39511156 | ||
| Synthetic fluoropeptides as pharmacologically useful compounds | Q39544431 | ||
| The role of autolysis in activity of the Ca2+-dependent proteinases (mu-calpain and m-calpain). | Q41269837 | ||
| Thrombin-induced platelet aggregation involves an indirect proteolytic cleavage of aggregin by calpain | Q41270240 | ||
| Shape change and uptake of 5-hydroxytryptamine in human blood platelets: action of neuropsychotropic drugs | Q41696861 | ||
| Calpain inhibition by peptide epoxides | Q41761276 | ||
| Calpain I activation is not correlated with aggregation in human platelets | Q41781541 | ||
| The effects of autolysis on the structure of chicken calpain II. | Q41868823 | ||
| The inactivation of the cysteinyl exopeptidases cathepsin H and C by affinity-labelling reagents | Q42112501 | ||
| Platelet-derived growth factor-induced alterations in vinculin distribution in porcine vascular smooth muscle cells | Q42208585 | ||
| Cytoplasmic free Ca2+ in human platelets: Ca2+ thresholds and Ca-independent activation for shape-change and secretion | Q42464048 | ||
| Fluoride-dependent calcium-induced platelet procoagulant activity shows that calpain is involved in increased phospholipid transbilayer movement | Q42501910 | ||
| Spectrin is associated with membrane-bound actin filaments in platelets and is hydrolyzed by the Ca2+-dependent protease during platelet activation | Q44227887 | ||
| Degradation of myocardial structural proteins in myocardial infarcted dogs is reduced by Ep459, a cysteine proteinase inhibitor | Q45353239 | ||
| Elucidation of calpain dependent phosphorylation of myosin light chain in human platelets. | Q45848433 | ||
| Probing of the structural stability of vimentin and desmin-type intermediate filaments with Ca2+-activated proteinase, thrombin and lysine-specific endoproteinase Lys-C. | Q46539891 | ||
| A new solid-state reagent to iodinate proteins. I. Conditions for the efficient labeling of antiserum | Q46622394 | ||
| Demonstration of a relationship between talin and P235, a major substrate of the calcium-dependent protease in platelets | Q46689898 | ||
| Intracellular Ca2+-dependent protease (CALPAIN) and its high-molecular-weight endogenous inhibitor (CALPASTATIN) | Q47301366 | ||
| Proteolysis of tubulin and microtubule-associated proteins 1 and 2 by calpain I and II. Difference in sensitivity of assembled and disassembled microtubules. | Q48120501 | ||
| Correlation between calpain-mediated cytoskeletal degradation and expression of platelet procoagulant activity. A role for the platelet membrane-skeleton in the regulation of membrane lipid asymmetry? | Q51784915 | ||
| Calpain II involvement in mitosis | Q57224475 | ||
| Peptidyl diazomethyl ketones are specific inactivators of thiol proteinases | Q67267798 | ||
| Ca2+-dependent protease in human platelets. Specific cleavage of platelet polypeptides in the presence of added Ca2+ | Q67600371 | ||
| Thiolprotease inhibitor, EST, can inhibit thrombin-induced platelet activation | Q68879172 | ||
| Inhibition of calpain in intact platelets by the thiol protease inhibitor E-64d | Q69329203 | ||
| Montreal platelet syndrome: a defect in calcium-activated neutral proteinase (calpain) | Q69352975 | ||
| Influence of a calcium dependent protease inhibitor on platelet activation and secretion | Q69458820 | ||
| Collagen-stimulated human platelet aggregation is mediated by endogenous calcium-activated neutral protease | Q69483215 | ||
| Synthesis of a new cell penetrating calpain inhibitor (calpeptin) | Q69831486 | ||
| Calcium-dependent proteolysis occurs during platelet aggregation | Q70158655 | ||
| Evidence for membrane-associated calpain I in human erythrocytes. Detection by an immunoelectrophoretic blotting method using monospecific antibody | Q72388558 | ||
| Ionomycin can elevate intraplatelet Ca2+ and activate phospholipase a without activating phospholipase C | Q72392374 | ||
| The thiol proteinase inhibitors, Z-Phe-PheCHN2 and Z-Phe-AlaCHN2, inhibit lysosomal protein degradation in isolated rat hepatocytes | Q72694707 | ||
| Calcium-dependent proteins in platelets response of calcium-activated protease in normal and thrombasthenic platelets to aggregating agents | Q72858361 | ||
| THE AGGREGATION OF BLOOD PLATELETS | Q76530970 | ||
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 497-502 | |
| P577 | publication date | 1991-03-01 | |
| P1433 | published in | Biochemical Journal | Q864221 |
| P1476 | title | Investigation of the role of calpain as a stimulus-response mediator in human platelets using new synthetic inhibitors | |
| P478 | volume | 274 ( Pt 2) |
| Q43614765 | A selective cysteine protease inhibitor is non-toxic and cerebroprotective in rats undergoing transient middle cerebral artery ischemia |
| Q67809975 | Additional Peptidyl Diazomethyl Ketones, Including Biotinyl Derivatives, Which Affinity-Label Calpain and Related Cysteinyl Proteinases |
| Q42796434 | Affinity labelling of the Ca(2+)-activated neutral proteinase (calpain) in intact human platelets |
| Q36255313 | Calpain regulates actin remodeling during cell spreading |
| Q42132232 | Comparative behaviour of calpain and cathepsin B toward peptidyl acyloxymethyl ketones, sulphonium methyl ketones and other potential inhibitors of cysteine proteinases |
| Q41188037 | Development and therapeutic potential of calpain inhibitors |
| Q44888020 | Dysregulation of the calpain-calpastatin system plays a role in the development of cerulein-induced acute pancreatitis in the rat. |
| Q71131484 | Hepatocellular carcinoma cells resist necrosis during anoxia by preventing phospholipase-mediated calpain activation |
| Q33572036 | Identification and optimization of a novel inhibitor of mitochondrial calpain 10 |
| Q37031593 | Improvement in recovery after experimental intracerebral hemorrhage using a selective cathepsin B and L inhibitor |
| Q37307187 | Inhibition of calpain blocks platelet secretion, aggregation, and spreading |
| Q41190407 | Isolation of a Chinese hamster ovary cell clone possessing decreased mu-calpain content and a reduced proliferative growth rate |
| Q33512916 | Proteomic and phospho-proteomic profile of human platelets in basal, resting state: insights into integrin signaling |
| Q72615845 | The affinity-labelling of cathepsin S with peptidyl diazomethyl ketones. Comparison with the inhibition of cathepsin L and calpain |
| Q24311357 | The major calpain isozymes are long-lived proteins. Design of an antisense strategy for calpain depletion in cultured cells |
Search more.